PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
301230 PharmaResources
- 28.25
- +0.90+3.29%
Market Closed Apr 25 15:00 CST
3.94BMarket Cap231.56P/E (TTM)
30.50High28.18Low122.80KlotVolume29.78Open27.35Pre Close356.39MTurnover15.98%Turnover Ratio231.56P/E (Static)139.59MShares45.4052wk High3.82P/B2.17BFloat Cap18.3152wk Low32.82Limit Up76.86MShs Float45.40Historical High21.88Limit Down8.48%Amplitude15.96Historical Low0.35Dividend TTM29.02Avg Price60.74KlotAsk1.25%Div YieldTTM100Lot Size52.33KlotBid
PharmaResources Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 5.15%492.92M | -3.22%341.35M | -11.36%216.24M | -8.99%109.74M | -1.09%468.79M | 8.89%352.72M | 22.33%243.95M | 3.98%120.59M | 19.69%473.98M | 23.88%323.92M |
| Refunds of taxes and levies | -46.32%5.54M | -60.17%5.2M | -91.82%988.53K | -94.24%518.47K | -38.51%10.31M | -17.76%13.06M | -3.91%12.08M | --9M | 1,737.74%16.77M | 4,585.09%15.88M |
| Cash received relating to other operating activities | 91.63%40.9M | 88.10%40.8M | -42.94%9M | 224.09%22.76M | 3.89%21.34M | 33.27%21.69M | 9.88%15.77M | -48.56%7.02M | 0.04%20.54M | -16.22%16.28M |
| Cash inflows from operating activities | 7.77%539.35M | -0.03%387.36M | -16.77%226.22M | -2.63%133.02M | -2.12%500.45M | 8.82%387.47M | 20.08%271.8M | 5.39%136.61M | 22.48%511.29M | 26.61%356.08M |
| Goods services cash paid | 25.07%161.72M | 6.48%111.08M | -0.20%78.19M | -7.83%37.45M | -8.24%129.3M | 12.80%104.32M | 40.04%78.34M | 52.85%40.63M | 20.96%140.9M | 8.04%92.48M |
| Staff behalf paid | 2.23%241.64M | 2.17%170.38M | 3.52%117.56M | -0.35%62.02M | 16.03%236.37M | 15.26%166.76M | 8.13%113.56M | 18.73%62.23M | 37.51%203.72M | 36.62%144.68M |
| All taxes paid | 37.59%10.7M | 39.83%13.4M | 77.27%10.77M | 212.58%6.74M | -36.99%7.78M | -21.70%9.58M | -31.51%6.08M | -69.20%2.16M | 1.86%12.34M | 15.75%12.24M |
| Cash paid relating to other operating activities | -58.15%44.43M | 32.00%71.39M | 9.50%41.3M | -2.74%17.54M | 92.87%106.15M | 52.39%54.08M | 184.04%37.71M | 12.53%18.03M | 54.74%55.04M | 44.39%35.49M |
| Cash outflows from operating activities | -4.40%458.49M | 9.41%366.25M | 5.14%247.82M | 0.56%123.74M | 16.40%479.59M | 17.50%334.75M | 28.72%235.7M | 20.61%123.05M | 31.92%412M | 25.69%284.89M |
| Net cash flows from operating activities | 287.68%80.86M | -59.97%21.11M | -159.81%-21.59M | -31.58%9.28M | -78.99%20.86M | -25.94%52.72M | -16.50%36.1M | -50.88%13.56M | -5.55%99.29M | 30.42%71.19M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -47.60%619.39M | -36.20%589.73M | -27.02%462.6M | 45.27%146.5M | 1,309.12%1.18B | 1,193.52%924.35M | 1,960.42%633.85M | 22,072.14%100.85M | 4,551.46%83.88M | 15,607.23%71.46M |
| Cash received from returns on investments | -42.20%3.44M | 667.73%5.57M | 68.37%5.08M | 265.92%1.69M | 3,903.88%5.94M | 4,935.34%726.01K | 157,259.01%3.02M | --461.08K | --148.45K | --14.42K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,022.03%145.86K | 284.62%50K | 525.00%50K | 525.00%50K | --13K | --13K | --8K | --8K | ---- | ---- |
| Cash received relating to other investing activities | ---- | -97.49%1.9M | --775.07K | -98.61%739.13K | ---- | --75.6M | ---- | --53.1M | ---- | ---- |
| Cash inflows from investing activities | -47.56%622.97M | -40.32%597.25M | -26.44%468.5M | -3.52%148.98M | 1,313.72%1.19B | 1,300.07%1B | 1,970.12%636.87M | 33,849.45%154.42M | 4,404.81%84.03M | 15,610.40%71.47M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -55.93%109.4M | -65.06%71.11M | -86.25%23.07M | -73.54%18.69M | 100.27%248.27M | 120.55%203.48M | 501.96%167.84M | 585.80%70.66M | 34.57%123.97M | 60.90%92.26M |
| Cash paid to acquire investments | -63.31%558.39M | -48.31%516.39M | -52.90%431.39M | -13.15%200.2M | 1,556.61%1.52B | 1,024.06%999M | 1,334.06%916M | 3,515.91%230.5M | --91.87M | --88.87M |
| Cash paid relating to other investing activities | ---- | -99.42%2.65M | ---- | ---- | ---- | --455.6M | --168M | --279.1M | ---- | ---- |
| Cash outflows from investing activities | -62.28%667.8M | -64.41%590.15M | -63.70%454.46M | -62.28%218.89M | 720.18%1.77B | 815.38%1.66B | 1,264.31%1.25B | 3,379.17%580.26M | 134.31%215.84M | 215.90%181.14M |
| Net cash flows from investing activities | 92.30%-44.82M | 101.08%7.09M | 102.28%14.04M | 83.58%-69.92M | -341.77%-582.28M | -499.48%-657.39M | -908.29%-614.96M | -2,524.88%-425.84M | -46.04%-131.81M | -92.78%-109.66M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --710M | ---- |
| Cash from borrowing | 23.54%19.65M | 96.55%19.65M | 96.55%19.65M | --7.34M | 29.95%15.91M | -18.22%10M | 21.31%10M | ---- | -53.35%12.24M | -24.40%12.23M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | --165.28K | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 23.54%19.65M | 93.35%19.65M | 96.55%19.65M | --7.34M | -97.80%15.91M | -16.87%10.17M | 21.31%10M | ---- | 2,652.16%722.24M | -24.40%12.23M |
| Borrowing repayment | 155.64%25.56M | 132.48%23.25M | 59.10%15.91M | ---- | -59.27%10M | -31.26%10M | -31.29%10M | ---- | -7.55%24.55M | -39.04%14.55M |
| Dividend interest payment | 26.94%49.27M | 28.57%35.47M | 23.27%33.88M | -11.67%96.06K | 4,853.27%38.82M | 4,604.38%27.58M | 7,094.88%27.48M | -50.53%108.75K | 0.19%783.66K | -2.10%586.35K |
| Cash payments relating to other financing activities | 254.00%82.42M | 341.43%71.93M | 442.84%49.65M | 385.03%22.04M | 63.01%23.28M | 61.53%16.29M | 48.99%9.15M | 32.16%4.54M | 52.18%14.28M | 78.76%10.09M |
| Cash outflows from financing activities | 118.11%157.26M | 142.47%130.64M | 113.25%99.44M | 375.76%22.14M | 81.97%72.1M | 113.61%53.88M | 121.26%46.63M | -43.34%4.65M | 7.88%39.62M | -16.22%25.22M |
| Net cash flows from financing activities | -144.89%-137.61M | -153.90%-110.99M | -117.81%-79.79M | -218.07%-14.8M | -108.23%-56.19M | -236.39%-43.71M | -185.46%-36.63M | 22.05%-4.65M | 6,610.86%682.62M | 6.72%-12.99M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 999.39%4.82M | 161.31%2.79M | 231.09%2.6M | 175.60%1.23M | -106.88%-535.57K | -86.29%1.07M | -86.73%785.94K | -91.79%-1.63M | 469.31%7.78M | 1,312.75%7.79M |
| Net increase in cash and cash equivalents | 84.35%-96.75M | 87.64%-80M | 86.21%-84.74M | 82.27%-74.21M | -193.96%-618.15M | -1,382.15%-647.32M | -2,392.30%-614.71M | -9,282.22%-418.57M | 28,760.46%657.89M | -158.89%-43.67M |
| Add:Begin period cash and cash equivalents | -82.02%135.5M | -82.02%135.5M | -82.02%135.5M | -82.02%135.5M | 687.08%753.64M | 687.08%753.64M | 687.08%753.64M | 687.08%753.64M | 2.44%95.75M | 2.44%95.75M |
| End period cash equivalent | -71.40%38.75M | -47.80%55.5M | -63.47%50.76M | -81.71%61.28M | -82.02%135.5M | 104.17%106.33M | 95.44%138.94M | 234.04%335.07M | 687.08%753.64M | -32.02%52.08M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.